Industry Symposium
Tuesday, April 21, 2009: 7:00 – 9:00 AM
Practical Seizure & Epilepsy Management: Special Considerations Across the Lifespan
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Outline seizure presentation, etiology, and clinical concerns in a variety of patient populations.
- Strategize evidence-based treatment regimens for seizure management in various clinical situations including patients with psychiatric and medical comorbidities, children, women in childbearing years, and the elderly.
- Apply clinical pharmacy principles to evaluate clinical cases and appropriately monitor treatment for seizures and epilepsy.
Agenda
| 7:00 – 7:30AM | Registration and Seating/Meal Function |
|---|---|
| 7:30 – 7:35 AM |
Welcome & Introductions Melody Ryan, PharmD, BCPP, MPH, BCPS, CGP (Activity Chair) |
| 7:35 – 8:45 AM |
Practical Seizure & Epilepsy Management: Special Considerations Across the Lifespan Melody Ryan, PharmD, BCPP, MPH, BCPS, CGP and Steve S. Chung, MD Case Studies with Interactive Questions
|
| 8:45 – 9:00 AM | Panel Discussion/Q&A |
Registration
Pre-registration for this symposium is not required. Registrants will be welcomed on a first-come, first-served basis. Although it is not anticipated that CPNP attendees will be turned away, please arrive at Grande 1-3 as early as possible to ensure a seat.
Accreditation and Designation of Credit
Creative Educational Concepts, Inc (CEC) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been assigned ACPE #245-000-09-020-L01-P and will award 1.5 contact hours (0.15 CEUs) of continuing education credit. CEC complies with the Criteria for Quality for continuing education programming. Statements of credit will be issued to those participants attending the program and completing a CE request form and will be mailed within 10 business days.
Supported By
![]()
![]()
![]()
Supported by independent educational grants from UCB and Ovation Pharmaceuticals.




